FDA Warning Letter — Lelypharma BV
The FDA took a Warning Letter action against Lelypharma BV on January 24, 2024 (Lelystad, Netherlands). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Lelypharma BV
- Date
- January 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Lelystad (Netherlands)